| Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? H Peinado, D Olmeda, A Cano Nature reviews cancer 7 (6), 415-428, 2007 | 3750 | 2007 |
| A molecular role for lysyl oxidase‐like 2 enzyme in snail regulation and tumor progression H Peinado, M del Carmen Iglesias‐de la Cruz, D Olmeda, K Csiszar, ... The EMBO journal 24 (19), 3446-3458, 2005 | 472 | 2005 |
| Snail silencing effectively suppresses tumour growth and invasiveness D Olmeda, M Jorda, H Peinado, A Fabra, A Cano Oncogene 26 (13), 1862-1874, 2007 | 345 | 2007 |
| Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor M Jordà, D Olmeda, A Vinyals, E Valero, E Cubillo, A Llorens, A Cano, ... Journal of cell science 118 (15), 3371-3385, 2005 | 285 | 2005 |
| β-Catenin regulation during the cell cycle: implications in G2/M and apoptosis D Olmeda, S Castel, S Vilaró, A Cano Molecular biology of the cell 14 (7), 2844-2860, 2003 | 270 | 2003 |
| SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells D Olmeda, G Moreno-Bueno, JM Flores, A Fabra, F Portillo, A Cano Cancer research 67 (24), 11721-11731, 2007 | 260 | 2007 |
| The morphological and molecular features of the epithelial-to-mesenchymal transition G Moreno-Bueno, H Peinado, P Molina, D Olmeda, E Cubillo, V Santos, ... Nature protocols 4 (11), 1591-1613, 2009 | 257 | 2009 |
| Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression AR de Molina, M Bánez-Coronel, R Gutiérrez, A Rodríguez-González, ... Cancer research 64 (18), 6732-6739, 2004 | 168 | 2004 |
| UNR/CSDE1 drives a post-transcriptional program to promote melanoma invasion and metastasis L Wurth, P Papasaikas, D Olmeda, N Bley, GT Calvo, S Guerrero, ... Cancer cell 30 (5), 694-707, 2016 | 163 | 2016 |
| Snai1 and Snai2 collaborate on tumor growth and metastasis properties of mouse skin carcinoma cell lines D Olmeda, A Montes, G Moreno-Bueno, JM Flores, F Portillo, A Cano Oncogene 27 (34), 4690-4701, 2008 | 155 | 2008 |
| Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine D Olmeda, D Cerezo-Wallis, E Riveiro-Falkenbach, PC Pennacchi, ... Nature 546 (7660), 676-680, 2017 | 146 | 2017 |
| Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth MA Abéngozar, S de Frutos, S Ferreiro, J Soriano, M Perez-Martinez, ... Blood, The Journal of the American Society of Hematology 119 (19), 4565-4576, 2012 | 141 | 2012 |
| In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis I Martínez-Corral, D Olmeda, R Diéguez-Hurtado, T Tammela, K Alitalo, ... Proceedings of the National Academy of Sciences 109 (16), 6223-6228, 2012 | 123 | 2012 |
| RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway D Alonso-Curbelo, E Riveiro-Falkenbach, E Pérez-Guijarro, M Cifdaloz, ... Cancer cell 26 (1), 61-76, 2014 | 115 | 2014 |
| Hyaluronic acid/chitosan-g-poly (ethylene glycol) nanoparticles for gene therapy: an application for pDNA and siRNA delivery M Raviña, E Cubillo, D Olmeda, R Novoa-Carballal, E Fernandez-Megia, ... Pharmaceutical research 27, 2544-2555, 2010 | 111 | 2010 |
| Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state D Cerezo-Wallis, M Contreras-Alcalde, K Troulé, X Catena, C Mucientes, ... Nature medicine 26 (12), 1865-1877, 2020 | 72 | 2020 |
| Zeb1 and S nail1 engage mi R‐200f transcriptional and epigenetic regulation during EMT A Díaz‐López, J Díaz‐Martín, G Moreno‐Bueno, EP Cuevas, V Santos, ... International journal of cancer 136 (4), E62-E73, 2015 | 68 | 2015 |
| p62/SQSTM1 fuels melanoma progression by opposing mRNA decay of a selective set of pro-metastatic factors P Karras, E Riveiro-Falkenbach, E Cañón, C Tejedo, TG Calvo, ... Cancer Cell 35 (1), 46-63. e10, 2019 | 57 | 2019 |
| Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system. I Martinez-Corral, L Stanczuk, M Frye, MH Ulvmar, R Diéguez-Hurtado, ... Angiogenesis 19 (3), 433-445, 2016 | 52 | 2016 |
| Metastatic risk and resistance to BRAF inhibitors in melanoma defined by selective allelic loss of ATG5 M García-Fernández, P Karras, A Checinska, E Cañón, GT Calvo, ... Autophagy 12 (10), 1776-1790, 2016 | 43 | 2016 |
